Fenwick & West Represents Neoforma in Acquisition by Global Healthcare Exchange

October 11, 2005

Fenwick & West LLP represented Neoforma, Inc. (Nasdaq: NEOF) in its recently announced agreement to be acquired by Global Healthcare Exchange, LLC (GHX). GHX provides an open and neutral electronic trading exchange, along with complementary products and services, through which buyers and sellers can collaborate to improve efficiencies in the healthcare supply chain. Under the terms of the merger agreement, Neoforma's stockholders generally will receive $10 per share in cash, for an approximate transaction value of $210 million. The transaction is subject to regulatory approvals and closing conditions, and is expected to close in early 2006.

The Fenwick & West transaction team consisted of Gordon Davidson, Douglas Cogen, David Michaels, Susan Muck, Mark Ostrau, Scott Leichtner, Mona Clee, Elizabeth Gartland, Blake Martell, Paul Dutton, John Lister, Michael Tang, Joseph Belichick, Morgan Fong and Timothy Fitzgibbon.

About Fenwick & West

Fenwick & West provides comprehensive legal services to high technology and life sciences clients of national and international prominence. The firm was ranked by MergerMarket as the #1 U.S. Legal Advisor for Technology Industry M&A in 2004.